Filgrastim
NEUPOGEN, RELEUKO
Leukocyte Growth Factor
NADAC/unit
$305.8916
No Shortage
Tier 1: 6.7%
PA Req: 26.7%
Filgrastim stimulates white blood cell production, used to prevent infections during chemotherapy.
vs. brand NEUPOGEN: Generic saves up to -2959% per unit
Market Intelligence
2025-03-26 Class II Recall: Amgen, Inc.
2025-03-26 Class II Recall: Amgen, Inc.
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.